Berg also highlighted the limitations of the DAPA ACT HF-TIMI 68 trial, stating that the trial was underpowered with a lower-than-anticipated event rate and short duration.

Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...

In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...